Atrial fibrillation and atrial cardiomyopathy - Two sides of the same coin?

American Heart Journal

Volumn 147, Issue 6, 2004, Pages 953-955

  Pedersen, Ole Dyg ^a   Køber, Lars ^b   Torp Pedersen, Christian ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CARDIOMYOPATHY; CARDIOVASCULAR RISK; CLINICAL TRIAL; DISEASE PREDISPOSITION; EDITORIAL; ENZYME INHIBITION; EPIDEMIOLOGICAL DATA; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM CONTRACTION; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART PACING; HISTOLOGY; HUMAN; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; RECURRENT DISEASE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ATRIAL FIBRILLATION; CARDIOMYOPATHIES; HUMANS; RENIN-ANGIOTENSIN SYSTEM;

EID: 3042749198     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.01.015     Document Type: Editorial

References (14)

1. Moe G.K., Abildskov J.A. Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. Am Heart J. 58:1959;59-70
2. Allessie M.A., Boyden P.A., Camm A.J., et al. Pathophysiology and prevention of atrial fibrillation. Circulation. 103:2001;769-777
3. Nattel S. New ideas about atrial fibrillation 50 years on. Nature. 415:2002;219-226
4. Wijffels M.C., Kirchhof C.J., Dorland R., et al. Atrial fibrillation begets atrial fibrillation a study in awake chronically instrumented goats. Circulation. 92:1995;1954-1968
5. Li D., Shinagawa K., Pang L., et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation. 104:2001;2608-2614
6. Fuster V., Ryden L.E., Asinger R.W., et al. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) developed in Collaboration with the North American Society of Pacing and Electrophysiology. Circulation. 104:2001;2118-2150
7. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 347:2002;1825-1833
8. Van Gelder I.C., Hagens V.E., Bosker H.A., et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 347:2002;1834-1840
9. Pedersen O.D., Bagger H., Kober L., et al. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation. 100:1999;376-380
10. Wachtell K., Letho M., Hornestam B., et al. Losartan reduces the risk of new-onset atrial fibrillation in hypertensive patients with electrocardiogram left ventricular hypertrofy the LIFE Study. Eur Heart J. 24:(Suppl):2003;504
11. Ueng K.C., Tsai T.P., Yu W.C., et al. Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation results of a prospective and controlled study. Eur Heart J. 24:2003;2090-2098
12. Madrid A.H., Bueno M.G., Rebollo J.M., et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation a prospective and randomized study. Circulation. 106:2002;331-336
13. Goette A., Arndt M., Rocken C., et al. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation. 101:2000;2678-2681
14. Nakashima H., Kumagai K., Urata H., et al. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation. 101:2000;2612-2617